Proactive Investors - Run By Investors For Investors

VentriPoint Diagnostics to showcase its VMS Plus heart system at Milan conference

The event has nearly 4,000 healthcare professionals from over 90 countries around the world
VentriPoint Diagnostics to showcase its VMS Plus heart system at Milan conference
Ventripoint is a heart imaging tech group

Medtech group VentriPoint Diagnostics Ltd (CVE:VPT) will showcase its next-generation VMS Plus heart imaging system at EuroEcho 2018 in Milan.

With nearly 4,000 healthcare professionals from over 90 countries around the world, EuroEcho is one of the world's largest cardiovascular imaging congress.

READ: VentriPoint Diagnostics reports that its new approved heart technology being used by internationally renowned pediatric cardiologist

"We are excited to showcase our next-generation VMS+ System to the European market. We will have live scanning in the booth to provide the opportunity for hands-on use by the cardiology community," said Mehran Mehrtash, the vice-president, the worldwide distributor of sales at VentriPoint.

The next-generation system is designed to use Artificial Intelligence (AI) to assess the performance of all four chambers of the heart from standard 2D echo images.

Artificial Intelligence (AI) is the future of cardiac imaging and is transforming clinical outcomes, says the company.

The conference is in Milan, Italy and runs from December 5 to 7, providing hands-on demonstrations of the next-generation VMS+ System.

Contact Giles Gwinnett at [email protected]

Follow Giles on Twitter @Gile74

View full VPT profile View Profile

VentriPoint Diagnostics Ltd. Timeline

Related Articles

Scientist
December 03 2018
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
Proton Therapy sign
October 10 2018
The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use